NON SELECTIVE BETA-BLOCKERS
BY
SHIVA HOSUR
WHAT ARE BETA BLOCKERS ??
 BETA BLOCKERS ARE THE DRUGS THAT BLOCK
THE ACTION OF CATECHOLAMINES MEDIATED
THROUGH β RECEPTORS
 ALL β BLOCKERS ARE COMPETATIVE
ANTAGONISTS
CLASSIFICATION
PHARMACOLOGICAL ACTIONS
 HEART – beta blockers decreases HR, FORCE OF
CONTRACTION, CARDIAC OUTPUT BP FALLS
 AV CONDUCTION IS DELAYED DUE TO BLOCKADE OF
BETA RECEPORS IN AV NODE ,THUS MYOCARDIAL
OXYGEN REQUIREMENT IS REDUCED DUE TO REDUCED
CARDIAC WORK.
 BETA-BLOCKERS PREVENTS EXERCISE –INDUCED IN HR
& FORCE OF CONTRACTION
PHARMACOLOGICAL ACTION
 RESPIRATORY TRACT- BLOCKADE OF β2 RECEPTORS IN
BRONCHIAL SMOOTH MUSCLE CAUSES AN INCREASES IN
AIRWAY RESISTANCE MAY PRECIPITATE ACCUTE ATTACK IN
ASTHMATICS.
 EYE- MANY BETA BLOCKERS REDUCES IOP BY DECREASED
SECRETION OF AQUEOUS HUMOUR
 OTHER EFFECTS- MANY BETA BLOCKERS IN HIGHER DOSES
SODIUM CHANNELS AND HAVE A LOCAL ANAESTHETIC
EFFECT- MEMBRANE STABLISING EFFECT
NON SELECIVE BETA BLOCKERS
 SOTALOL-NON SELECTIVE ,HAS ADDITIONAL POTASSIUM
CHANNEL BLOCKING PROPERTY.
 NADOLOL- LONG ACTING BETA BLOCKER ,USED IN
HYPERTENSION,ANGINA ,OESOPHAGEAL VARICES,MIGRANE
PROPHYLAXIS AND IN TREMORS.
BETA BLOCKER IN EYE
PINDOLOL OXPRENOLOL & PENBUTALOL
 NON SELECTIVE, PARTIAL AGONISTS ACT BETA 1 & BETA 2
RECEPTORS .
 PENBUTOLOL IN ADDITION HAS WEAK INTRINSIC SYMPATHOMIMETIC
ACTIVITY.
ADVANTAGES
 MILDER BRADYCARDIA
 MILDER MYOCARDIAL DEPRESSION
 BETTER TOLERATED IN ASTHMATICS
 MILDER EFFECT ON LIPID PROFILE
 LESS CHANCES OF REBOUND HYPERTENSION ON WITHDRAWAL.
DIS ADVANTAGE
 NOT SUITABLE FOR PROPHYLAXIS OF MIGRANE AND
MYOCARDIAL INFARCTION
DOSES
 PINDOLOL-10-30 mg
 OXPRENOLOL -40-80mg
 PENBUTALOL-20-80mg
 LEVATOL 20,40mg
ADVANTAGES OF CARDIO SELECTIVEβ BLOCKERS
OVER NON SELECTIVE β BLOCKERS
I. SAFER IN ASTHMATICS
II. SAFER IN DIABETES
III. PERIPHERAL VASCULAR DISEASES
IV. LESS DELETERIOUS EFFECTS ON LIPID PROFILE
V. LESS LIABLE TO IMPAIR EXERCISE CAPACITY
Third generation beta blockers
 THESE INCLUDES ,CARVEDILOL,CARTELOL,LAVETALOL,BUCINDALOL
 THESE ARE BETA BLOCKERS WITH ADDITIONAL VASODIALATORY
PROPERTIES
 CARTELOL- NON SELECTIVE BETA BLOCKER WITH PARTIAL
AGONISTIC ACTIVITY AT β1 RECEPTORS AND THUS CAUSES
BRADYCARDIA
 CARVEDILOL- BLOCKS β1,β2 & α1 RECEPTORS IT ALSO HAS
MEMBRANE STABILIZING AND ANTI INFLAMMATORY PROPERTIES.
Non selective beta blockers

Non selective beta blockers

  • 1.
  • 2.
    WHAT ARE BETABLOCKERS ??  BETA BLOCKERS ARE THE DRUGS THAT BLOCK THE ACTION OF CATECHOLAMINES MEDIATED THROUGH β RECEPTORS  ALL β BLOCKERS ARE COMPETATIVE ANTAGONISTS
  • 3.
  • 4.
    PHARMACOLOGICAL ACTIONS  HEART– beta blockers decreases HR, FORCE OF CONTRACTION, CARDIAC OUTPUT BP FALLS  AV CONDUCTION IS DELAYED DUE TO BLOCKADE OF BETA RECEPORS IN AV NODE ,THUS MYOCARDIAL OXYGEN REQUIREMENT IS REDUCED DUE TO REDUCED CARDIAC WORK.  BETA-BLOCKERS PREVENTS EXERCISE –INDUCED IN HR & FORCE OF CONTRACTION
  • 5.
    PHARMACOLOGICAL ACTION  RESPIRATORYTRACT- BLOCKADE OF β2 RECEPTORS IN BRONCHIAL SMOOTH MUSCLE CAUSES AN INCREASES IN AIRWAY RESISTANCE MAY PRECIPITATE ACCUTE ATTACK IN ASTHMATICS.  EYE- MANY BETA BLOCKERS REDUCES IOP BY DECREASED SECRETION OF AQUEOUS HUMOUR  OTHER EFFECTS- MANY BETA BLOCKERS IN HIGHER DOSES SODIUM CHANNELS AND HAVE A LOCAL ANAESTHETIC EFFECT- MEMBRANE STABLISING EFFECT
  • 6.
    NON SELECIVE BETABLOCKERS  SOTALOL-NON SELECTIVE ,HAS ADDITIONAL POTASSIUM CHANNEL BLOCKING PROPERTY.  NADOLOL- LONG ACTING BETA BLOCKER ,USED IN HYPERTENSION,ANGINA ,OESOPHAGEAL VARICES,MIGRANE PROPHYLAXIS AND IN TREMORS.
  • 7.
  • 11.
    PINDOLOL OXPRENOLOL &PENBUTALOL  NON SELECTIVE, PARTIAL AGONISTS ACT BETA 1 & BETA 2 RECEPTORS .  PENBUTOLOL IN ADDITION HAS WEAK INTRINSIC SYMPATHOMIMETIC ACTIVITY. ADVANTAGES  MILDER BRADYCARDIA  MILDER MYOCARDIAL DEPRESSION  BETTER TOLERATED IN ASTHMATICS  MILDER EFFECT ON LIPID PROFILE  LESS CHANCES OF REBOUND HYPERTENSION ON WITHDRAWAL.
  • 12.
    DIS ADVANTAGE  NOTSUITABLE FOR PROPHYLAXIS OF MIGRANE AND MYOCARDIAL INFARCTION DOSES  PINDOLOL-10-30 mg  OXPRENOLOL -40-80mg  PENBUTALOL-20-80mg  LEVATOL 20,40mg
  • 13.
    ADVANTAGES OF CARDIOSELECTIVEβ BLOCKERS OVER NON SELECTIVE β BLOCKERS I. SAFER IN ASTHMATICS II. SAFER IN DIABETES III. PERIPHERAL VASCULAR DISEASES IV. LESS DELETERIOUS EFFECTS ON LIPID PROFILE V. LESS LIABLE TO IMPAIR EXERCISE CAPACITY
  • 14.
    Third generation betablockers  THESE INCLUDES ,CARVEDILOL,CARTELOL,LAVETALOL,BUCINDALOL  THESE ARE BETA BLOCKERS WITH ADDITIONAL VASODIALATORY PROPERTIES  CARTELOL- NON SELECTIVE BETA BLOCKER WITH PARTIAL AGONISTIC ACTIVITY AT β1 RECEPTORS AND THUS CAUSES BRADYCARDIA  CARVEDILOL- BLOCKS β1,β2 & α1 RECEPTORS IT ALSO HAS MEMBRANE STABILIZING AND ANTI INFLAMMATORY PROPERTIES.